Login

Fubo CEO David Gandler discusses the company's 4Q earnings and the competitive landscape of sports streaming with Diane King Hall. 00:10:00

Share On Facebook Share On Twitter

David Gandler is Co-founder and CEO of FuboTV Inc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
"Pioneering Quantitative Investing: John Chisholm on Machine Learning, ESG, and Value Investing"
00:10:00
There is plenty to do for Digia | Timo Levoranta, CEO, Digia OyjDIGIA:HEX
00:10:00
Emphasizing Talent Development and Environmental Responsibility in Energy Leadership | Manny Rubio , CEO, Aboitiz Power Corp.
00:10:00
Sprott Asset Management CEO John Ciampaglia discusses the launch of the Sprott Energy Transition with Proactive's Natalie Stoberman.
00:00:00
NetScientific PLC's purchase of interest in Vortex Bio showcases “deep stake” transatlantic strategy - Dr. Ilian Iliev CHIEF EXECUTIVE OFFICER, Netscientific
00:10:00
Navigating Rising Risks: David Kudla's Investment Strategy and Opportunities | David Kudla, CEO, Mainstay Capital Management.
00:10:00
Develops cellbased immuno-therapies for the treatment of severe chronic inflammatory diseases|Stephane Boissel, CEO,Txcell
00:10:00
From Chemical Engineering to Financial Planning at Illuminate Wealth Management | Ben Hockema, Founder, Illuminate Wealth Management.
00:10:00
Middle Market Lending Trends and Industry Focus
00:10:00
Thomas Peterffy, Chairman of Interactive Brokers, discusses the company's quarterly earnings on "Closing Bell Overtime."
00:10:00
Fission Uranium Development in Canada's Athabasca Basin
00:10:00
Introducing Schwallier Wealth Management 1 | Adam Schwallier, President, Schwallier Wealth Management LLC.

© 2026 Nehu